It doesn’t seem possible. But they say it’s true. A small team of Israeli scientists is telling the world that they will have the first “complete cure” for cancer within a year. And not only that, but they claim it will be a short term, cheap and effective method of treatment and will have no or minimal side-effects.
It sounds fantastical, especially considering that an estimated 18.1 million new cancer cases are diagnosed worldwide each year, according to reports by the International Agency for Research on Cancer. Further, every sixth death in the world is due to cancer, making it the second leading cause of death (second only to cardiovascular disease).
The revolutionary cure, dubbed MuTaTo, is being developed by Accelerated Evolution Biotechnologies Ltd. and will apparently be available for cancer patients early next year.
MuTaTo reportedly uses a combination of cancer-targeting peptides and a unique toxin that only targets and terminates cancer cells. It leaves alone healthy cells and tissues in the process.
The Israeli scientists claim that that the cure can be hyper-personalised to suit the needs of each and every patient.
They have successfully conducted trials on mice and are now fast-tracking to conduct human trials through 2019.
If the trials complete successfully, it will save millions of lives in the coming years.
The chairman of the company, Dan Aridor has said that,
“Our cancer cure will be effective from day one, will last a duration of a few weeks and will have no or minimal side-effects at a much lower cost than most other treatments on the market. Our solution will be both generic and personal.”